Nea Management Company, LLC Savara Inc Put Options Transaction History
Nea Management Company, LLC
- $1.05 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SVRA
# of Institutions
140Shares Held
158MCall Options Held
54.8KPut Options Held
4.1K-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$54.6 Million16.36% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$38.3 Million8.25% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$35.5 Million2.0% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$34.1 Million2.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.12MShares$25.2 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $354M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.